Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 1 relevant journal, 45 Conferences, 60 National Symposiums are presently dedicated exclusively to Insulin drug delivery and about 169 articles are being published on Insulin drug delivery.
Insulin Drug Delivery is the use of insulin and similar proteins as a medication to treat disease. Insulin comes in a number of different types including short acting (such as regular insulin) and long acting (such as NPH insulin). The initial sources of insulin for clinical use in humans were cow, horse, pig or fish pancreases. Insulin from these sources is effective in humans as it is nearly identical to human insulin (three amino acid difference in bovine insulin, one amino acid difference in porcine). Differences in suitability of beef-, pork-, or fish-derived insulin for individual patients have historically been due to lower preparation purity resulting in allergic reactions to the presence of non-insulin substances.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
The global market for emerging insulin drug and delivery technologies is very dynamic and is developing at a fast pace. The industry has progressed steadily during the past decade and will continue to sustain growth in the coming four to five years. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles, leading to a steady market for these technologies. New advancements, new product launches, along with increased awareness and early detection of the disease are expected to influence the market growth in the foreseeable future.
Market Analysis:
Evaluation of emerging technologies in the insulin drug and delivery field that have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. The global market for insulin drug and delivery devices totalled $24 billion in 2012. The overall insulin drug and device market is projected to be worth $25.7 billion by 2013 and $40.2 billion by 2018, a five-year compound annual growth rate (CAGR) for of 9.3% from 2013 to 2018.
International symposium and workshops
Relevant Societies and Associations
List of Best International Conferences
Companies
This page will be updated regularly.
This page was last updated on April 23, 2024